Scarica l'app Stockscreener
1.84
3.95%
0.07
Dopo l'orario di chiusura:
1.84
Precedente Chiudi:
$1.77
Aprire:
$1.77
Volume 24 ore:
48,052
Relative Volume:
0.39
Capitalizzazione di mercato:
$79.04M
Reddito:
$51.13M
Utile/perdita netta:
$-93.80M
Rapporto P/E:
-0.8251
EPS:
-2.23
Flusso di cassa netto:
$-129.10M
1 W Prestazione:
-6.12%
1M Prestazione:
+4.55%
6M Prestazione:
+34.31%
1 anno Prestazione:
-45.07%
Intervallo 1D:
$1.77
$1.87
Intervallo di 1 settimana:
$1.72
$1.91
Portata 52W:
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
Nome
Repare Therapeutics Inc
Settore
Industria
Telefono
(857) 412-7018
Indirizzo
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Confronta RPTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.84 | 76.04M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-06-09 | Aggiornamento | Stifel | Hold → Buy |
| 2023-02-03 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | Iniziato | CapitalOne | Overweight |
| 2022-04-12 | Downgrade | Stifel | Buy → Hold |
| 2022-03-17 | Ripresa | Goldman | Buy |
| 2021-09-23 | Iniziato | Stifel | Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Buy |
| 2021-06-28 | Iniziato | Guggenheim | Buy |
| 2021-03-01 | Iniziato | Berenberg | Buy |
| 2020-10-28 | Iniziato | Northland Capital | Outperform |
| 2020-07-14 | Iniziato | Cowen | Outperform |
| 2020-07-14 | Iniziato | Goldman | Neutral |
| 2020-07-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-14 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Repare Therapeutics Inc Borsa (RPTX) Ultime notizie
Is Repare Therapeutics Inc. stock near bottom after declineEarnings Recap Summary & Weekly Top Gainers Trade List - newser.com
Analyzing Repare Therapeutics Inc. with multi timeframe chartsVolume Spike & Expert Curated Trade Setups - newser.com
Candlestick signals on Repare Therapeutics Inc. stock todayGold Moves & Fast Exit and Entry Strategy Plans - newser.com
How to monitor Repare Therapeutics Inc. with trend dashboardsWeekly Stock Summary & Technical Buy Zone Confirmations - newser.com
Volume spikes in Repare Therapeutics Inc. stock – what they meanOptions Play & Long-Term Capital Growth Ideas - newser.com
Repare Therapeutics Inc. stock volume spike explainedJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Published on: 2025-11-01 00:17:06 - newser.com
Is Repare Therapeutics Inc. stock attractive for ETFs2025 Momentum Check & Weekly Sector Rotation Insights - newser.com
Repare Therapeutics (RPTX) Projected to Post Earnings on Thursday - MarketBeat
Why Repare Therapeutics Inc. stock remains resilient2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Real time scanner hits for Repare Therapeutics Inc. explained2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
How to interpret RSI for Repare Therapeutics Inc. stockJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Risk adjusted return profile for Repare Therapeutics Inc. analyzedJuly 2025 Outlook & Stepwise Entry/Exit Trade Alerts - newser.com
How Repare Therapeutics Inc. stock compares to industry benchmarksQuarterly Trade Report & Low Risk Entry Point Guides - newser.com
Repare Therapeutics Inc. (RPTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
HC Wainwright Issues Positive Outlook for RPTX Earnings - MarketBeat
Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely - Yahoo Finance
Q3 EPS Forecast for Repare Therapeutics Increased by Analyst - Defense World
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Average Rating of "Hold" from Analysts - MarketBeat
Q1 Earnings Forecast for RPTX Issued By HC Wainwright - MarketBeat
Can Repare Therapeutics Inc. stock deliver sustainable ROEQuarterly Earnings Report & High Accuracy Buy Signal Tips - Fundação Cultural do Pará
Repare Therapeutics stock price target cut as H.C. Wainwright questions drug candidate - Investing.com Nigeria
Repare Therapeutics (NASDAQ:RPTX) Given New $3.00 Price Target at HC Wainwright - Defense World
HC Wainwright & Co. Maintains Repare Therapeutics (RPTX) Buy Recommendation - Nasdaq
Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look - TipRanks
RPTX Analyst Forecasts - Quiver Quantitative
HC Wainwright Has Lowered Expectations for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat
RPTX: Analyst Lowers Target Price While Maintaining Buy Rating | - GuruFocus
Can Repare Therapeutics Inc. stock beat analyst upgrades2025 Big Picture & Low Drawdown Investment Ideas - fcp.pa.gov.br
Repare Therapeutics Inc Azioni (RPTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):